Detalhe da pesquisa
1.
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study).
Br J Haematol
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654616
2.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936697
3.
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood
; 137(25): 3495-3506, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598678
4.
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
Blood
; 135(13): 996-1007, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977002
5.
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper.
Hematol Oncol
; 40(4): 505-517, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488888
6.
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
N Engl J Med
; 377(13): 1250-1260, 2017 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28953447
7.
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
Blood
; 132(1): 49-58, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666118
8.
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Blood
; 130(16): 1800-1808, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28774879
9.
How I manage patients with relapsed/refractory diffuse large B cell lymphoma.
Br J Haematol
; 182(5): 633-643, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808921
10.
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Haematologica
; 103(5): 840-848, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29351986
11.
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients.
Haematologica
; 103(8): 1278-1287, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724903
12.
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 179(3): 439-448, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770576
13.
Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study.
Psychooncology
; 26(1): 118-124, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26940829
14.
Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study.
Psychooncology
; 26(12): 2086-2093, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28316129
15.
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.
Br J Haematol
; 175(3): 462-466, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27611233
16.
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
Am J Hematol
; 96(9): E353-E356, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152612
17.
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
Blood
; 121(5): 822-9, 2013 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223431
18.
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.
Ann Hematol
; 94(4): 633-41, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25630297
19.
Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma.
Biol Blood Marrow Transplant
; 20(12): 1905-11, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072780
20.
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
Blood
; 119(22): 5104-10, 2012 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22337714